Atlas Trials

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

Clinical trial NCT03077451 · COMPLETED

Trial details

NCT number
NCT03077451
Sponsor
AIDS Malignancy Consortium
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Kaposi SarcomaSkin Kaposi Sarcoma
Start date
2017-03-13
Primary completion
2022-05-23
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.